ClinConnect ClinConnect Logo
Search / Trial NCT03849521

Plaque Calcium Characterization and Ruptured Plaques

Launched by LI MIN · Feb 20, 2019

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Atherosclerosis Calcium Mr

ClinConnect Summary

This clinical trial is studying a new imaging technique called ultrashort echo time (UTE) MRI, which helps doctors see and measure calcium buildup in the arteries, particularly in patients with vulnerable plaques that may lead to serious heart problems. The researchers want to find out if this advanced imaging can help identify patients who are at higher risk for complications and if it can distinguish between those who have symptoms and those who do not.

To participate in the study, individuals must be scheduled for a procedure to clear blocked carotid arteries, either through surgery or a stent. However, people with certain conditions, such as having metal implants like pacemakers or experiencing severe anxiety in confined spaces, cannot join. Participants will undergo UTE MRI scans, which are non-invasive and aim to provide valuable information about their arterial health. This research could lead to better ways to predict and manage heart disease in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients referred for carotid endarterectomy or stent were prospectively enrolled.
  • Exclusion Criteria:
  • Patients with ferromagnetic metal, active implants such as pacemakers, aneurysm clips, known claustrophobia, and those who were unable to provide informed consent were excluded from enrollment.

About Li Min

Li Min is a leading clinical trial sponsor dedicated to advancing medical research and innovation. With a strong focus on developing groundbreaking therapies, Li Min collaborates with healthcare professionals and research institutions to conduct rigorous clinical trials across various therapeutic areas. Committed to upholding the highest standards of ethical practice and regulatory compliance, Li Min prioritizes patient safety and scientific integrity. Through its comprehensive approach to clinical development, Li Min aims to bring transformative solutions to market, ultimately improving patient outcomes and enhancing the quality of healthcare globally.

Locations

Jinan, Shandong, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials